Motivational Interviewing for Adherence Problems in Cystic Fibrosis

Overview

Journal Pediatr Pulmonol

Specialties Pediatrics
Pulmonary Medicine

Date 2010 Feb 11

PMID 20146366

Citations 20

Authors

Alistair J A Duff

Gary J Latchford

Affiliations

Soon will be listed here.

Abstract

This review focuses on adherence in cystic fibrosis (CF), and the factors known to influence it. In particular, it discusses the importance of effective communication in clinical settings and considers the evidence for the effectiveness of motivational interviewing (MI), to increase adaptation and adherence in physical health and CF. The review also contains an overview of the key concepts of MI, its' practice in medical settings and recommendations on how to adopt MI techniques in the routine care of people with CF.

Citing Articles

Treatment of Psychological Symptoms in Patients with Cystic Fibrosis.

Campagna G, Tagliati C, Giuseppetti G, Ripani P J Clin Med. 2024; 13(19).

PMID: 39407865 PMC: 11476740. DOI: 10.3390/jcm13195806.

Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis.

Jones M, Moffatt F, Harvey A, Ryan J Cochrane Database Syst Rev. 2023; 7:CD013610.

PMID: 37462324 PMC: 10353490. DOI: 10.1002/14651858.CD013610.pub2.

A Participatory Approach Involving Patients with Cystic Fibrosis and Healthcare Professionals for the Co-Design of an Adherence-Enhancing Intervention Toolkit.

Viprey M, Mougeot F, Dima A, Haesebaert J, Occelli P, Durieu I Patient Prefer Adherence. 2023; 17:995-1004.

PMID: 37063606 PMC: 10103710. DOI: 10.2147/PPA.S389792.

Transition to adult services: the current and potential role of the UK hospital pharmacist.

Trivedi A, Mohamad S, Sharma S, Ganapathi J, Adodra A, Goddings A Eur J Hosp Pharm. 2022; 30(e1):e70-e75.

PMID: 35732427 PMC: 10086734. DOI: 10.1136/ejhpharm-2022-003254.

Use of mucoactive agents in cystic fibrosis: A consensus survey of Italian specialists.

Volpi S, Carnovale V, Colombo C, Raia V, Blasi F, Pappagallo G Health Sci Rep. 2022; 5(4):e604.

PMID: 35677472 PMC: 9169509. DOI: 10.1002/hsr2.604.